Skip to main content

Table 1 Baseline characteristics of the patients (per protocol population)

From: Gaviscon® vs. omeprazole in symptomatic treatment of moderate gastroesophageal reflux. a direct comparative randomised trial

 

Gaviscon®

N = 120

Omeprazole

N = 121

Age, years: mean (SD)

46.3 (10.7)

44.5 (12.2)

Women: N (%)

73 (60.8)

65 (53.7)

Weight, kg: mean (SD)

73.3 (14.8)

74.5 (16.1)

BMI, kg/m2: mean (SD)

26.0 (5.2)

26.2 (4.7)

BMI ≥ 30 kg/m2: N (%)

19 (15.8)

23 (19.0)

GERD, time to diagnosis, years: mean (SD)

4.7 (6.3)

5.3 (7.3)

History of upper endoscopy: N (%)

34 (28.3)

44 (36.4)

Number of days with heartburn per week

- 2: N (%)

9 (7.5)

6 (5.0)

- 3: N (%)

29 (24.2)

24 (19.8)

- 4: N (%)

35 (29.2)

27 (22.3)

- 5: N (%)

17 (14.2)

28 (23.1)

- 6: N (%)

30 (25.0)

36 (29.8)

- Mean: N (SD)

4.3 (1.3)

4.5 (1.2)

Heartburn

- Mild: N (%)

10 (8.3)

15 (12.4)

- Moderate: N (%)

83 (69.2)

73 (60.3)

- Severe: N (%)

27 (22.5)

33 (27.3)

Heartburn-related pain (VAS), mm: mean (SD)

52 (22)

53 (22)

Systolic BP, mmHg: mean (SD)

124.8 (10.8)

125.4 (11.0)

Diastolic BP, mmHg: mean (SD)

74.4 (8.5)

74.2 (8.2)

Heart rate, beat/min: mean (SD)

72.6 (7.5)

72.1 (9.0)

Smoking, Yes: N (%)

26 (21.7)

27 (22.3)

Alcohol consumption, Yes: N (%)

29 (24.2)

37 (30.6)

Living alone: N (%)

25 (20.8)

37 (30.6)

In couple: N (%)

95 (79.2)

84 (69.4)

Place of residence

- Rural

37 (30.8)

37 (30.6)

- Suburban

35 (29.2)

34 (28.1)

- Town

33 (27.5)

25 (20.7)

- City

15 (12.5)

25 (20.7)

Occupationally active

91 (75.8)

80 (66.1)